跳至主要内容
临床试验/NCT04726046
NCT04726046已完成1 期

Prospective Randomized Control Study of Clinical Effectiveness of Prophylactic Antibiotics Therapy in Laparoscopic Cholecystectomy on Infection Rate

Chonbuk National University Hospital0 个研究点目标入组 529 人开始时间: 2014年4月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
1 期
状态
已完成
入组人数
529
主要终点
surgical complication

研究概览

简要总结

529 patients performed elective LCC at Chonbuk National University Hospital between April 2014 and August 2015. Total 509 patients were enrolled by inclusion criteria.

They were randomized studied by comparing with antibiotic group (n=249, AG, cefotetan 1g, 1 dose/prophylactic) and non-antibiotic group (n=260, NAG) by table of random numbers. The clinical variables were pre and post-operatively blood tests enclude WBC, ESR, CRP, body temperatures, symptoms and imaging of chest x-ray to evaluate the infections.

详细描述

529 patients performed elective LCC at Chonbuk National University Hospital between April 2014 and August 2015. Total 509 patients were enrolled by inclusion criteria. They were randomized studied by comparing with antibiotic group (n=249, AG, cefotetan 1g, 1 dose/prophylactic) and non-antibiotic group (n=260, NAG) by table of random numbers. The clinical variables were pre and post-operatively blood tests enclude WBC, ESR, CRP, body temperatures, symptoms and imaging of chest x-ray to evaluate the infections.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Investigator)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients who have diagnosed -cholecystitis with / without GB stone, GB polyp

排除标准

  • Suspected cholangitis and GB cancer
  • CBD stone history
  • Preoperative administration of antibiotics within 7days.
  • Suspected pregnancy
  • Open conversion.
  • Patients refuse this study

研究组 & 干预措施

Antibiotic treatment group

Experimental

They were Antibiotic treatment group (AG, cefotetan 1g, 1 dose/prophylactic) before surgery.

干预措施: Cefotetan (Drug)

结局指标

主要结局

surgical complication

时间窗: 30days

surgical site infection

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验